Premarket Mover: Titan Pharmaceuticals, Inc. common stock (TTNP) Up 7.07%
Tuesday, January 31, 2023 07:37 AM | InvestorsObserver Analysts
Mentioned in this article
Titan Pharmaceuticals, Inc. common stock (TTNP) is up Tuesday morning, with the stock increasing 7.07% in pre-market trading to 1.06.
TTNP's short-term technical score of 73 indicates that the stock has traded more bullishly over the last month than 73% of stocks on the market. In the Biotechnology industry, which ranks 114 out of 146 industries, the stock ranks higher than 78% of stocks.
Titan Pharmaceuticals, Inc. common stock has risen 26.92% over the past month, closing at $0.80 on January 3. During this period of time, the stock fell as low as $0.80 and as high as $1.09. TTNP has an average analyst recommendation of Sell.
TTNP has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on TTNP!
Titan Pharmaceuticals, Inc. common stock has a Long-Term Technical rank of 36. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 64% of the market scoring higher. In the Biotechnology industry which is number 128 by this metric, TTNP ranks better than 128% of stocks.
